Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-23 Purchase |
2023-05-25 4:05 pm |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
5,000 | $5.5 | $27,500 | 42,165 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 09:13 am |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
10,000 | $4.76 | $47,600 | 35,873 (Direct) |
View |
| 2022-06-01 Purchase |
2022-06-01 4:31 pm |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
10,000 | $4.23 | $42,300 | 24,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Option Award |
2024-03-04 6:04 pm |
N/A 2034-02-28 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:07 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-12-21 Option Award |
2022-12-22 4:05 pm |
N/A 2032-12-20 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-22 6:01 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
6,500 | $7.51 | 14,500 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:11 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-12-13 Option Award |
2021-12-14 5:37 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
5,000 | $12.28 | 8,000 (Direct) |
View |
| 2021-11-29 Option Award |
2021-12-01 6:00 pm |
N/A 2031-11-28 |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
180,000 | $0 | 180,000 (Direct) |
View |
Ownership |
2021-12-01 5:56 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Chardonnet Laurent Chief Financial Officer |
0 | $0 | 3,000 (Direct) |
View |
| 2021-02-09 Option Award |
2021-02-11 9:28 pm |
N/A N/A |
Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer |
205,000 | $0 | 211,266 (Direct) |
View |
| 2020-10-30 Option Award |
2021-02-11 9:28 pm |
N/A N/A |
Axcella Health Inc. | AXLA | Chardonnet Laurent Chief Financial Officer |
2,601 | $3.6 | 211,266 (Direct) |
View |